Protective immunity to Schistosoma haematobium infection is primarily an anti-fecundity response stimulated by the death of adult worms

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 33, 2012, Pages 13347-13352

  Mitchell, Kate M ^a,b   Mutapi, Francisca ^a   Savill, Nicholas J ^a   Woolhouse, Mark E J ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Acquired immunity; Immunoepidemiology; Schistosomiasis

Indexed keywords

ANTIBODY;

ADOLESCENT; ANTIBODY RESPONSE; ARTICLE; CELL POPULATION; CERCARIA; CHILD; DEATH; DISEASE PREDISPOSITION; DISEASE TRANSMISSION; FERTILITY; HUMAN; IMMUNITY; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHISTOSOMA HEMATOBIUM; SCHISTOSOMIASIS HAEMATOBIA; SCHOOL CHILD; SENSITIVITY ANALYSIS; SIMULATION; STOCHASTIC MODEL; URINALYSIS; WORM EGG;

ADOLESCENT; AGING; ANIMALS; ANTIBODIES, HELMINTH; CHILD; FERTILITY; HUMANS; IMMUNITY; LIFE CYCLE STAGES; MODELS, IMMUNOLOGICAL; SCHISTOSOMA HAEMATOBIUM; SCHISTOSOMIASIS HAEMATOBIA; SURVIVAL ANALYSIS;

EID: 84865165582     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1121051109     Document Type: Article

References (45)

1. World Health Organization (2010) First WHO Report on Neglected Tropical Diseases: Working to Overcome the Global Impact of Neglected Tropical Diseases (WHO, Geneva).
2. van der Werf MJ, et al. (2003) Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa. Acta Trop 86:125-139.
3. Capron A, Capron M, Riveau G (2002) Vaccine development against schistosomiasis from concepts to clinical trials. Br Med Bull 62:139-148. (Pubitemid 34832476)
4. Woolhouse MEJ, Hagan P (1999) Seeking the ghost of worms past. Nat Med 5:1225-1227. (Pubitemid 29535586)
5. Mutapi F, et al. (2008) Age-related and infection intensity-related shifts in antibody recognition of defined protein antigens in a schistosome-exposed population. J Infect Dis 198:167-175. (Pubitemid 352019281)
6. Fisher AC (1934) A study of the schistosomiasis of the Stanleyville district of the Belgian Congo. Trans R Soc Trop Med Hyg 28:277-306.
7. Clarke VD (1966) The influence of acquired resistance in the epidemiology of bilharziasis. Cent Afr J Med 12:1-30.
8. Hellriegel B (2001) Immunoepidemiology-bridging the gap between immunology and epidemiology. Trends Parasitol 17:102-106.
9. Chan MS, Isham VS (1998) A stochastic model of schistosomiasis immuno-epidemiology. Math Biosci 151:179-198. (Pubitemid 28381355)
10. Duerr HP, Dietz K, EichnerM(2003) On the interpretation of age-intensity profiles and dispersion patterns. Parasitology 126:87-101. (Pubitemid 36246203)
11. Galvani AP (2003) Immunity, antigenic heterogeneity, and aggregation of helminth parasites. J Parasitol 89:232-241.
12. Woolhouse MEJ (1998) Patterns in parasite epidemiology: The peak shift. Parasitol Today 14:428-434.
13. Ndhlovu P, et al. (1996) Age-related antibody profiles in Schistosoma haematobium infections in a rural community in Zimbabwe. Parasite Immunol 18:181-191. (Pubitemid 26124705)
14. Mutapi F, Ndhlovu PD, Hagan P, Woolhouse MEJ (1997) A comparison of humoral responses to Schistosoma haematobium in areas with low and high levels of infection. Parasite Immunol 19:255-263. (Pubitemid 27293345)
15. Grimm V, et al. (2005) Pattern-oriented modeling of agent-based complex systems: Lessons from ecology. Science 310:987-991. (Pubitemid 41611904)
16. Mitchell KM, Mutapi F, Savill NJ,Woolhouse MEJ (2011) Explaining observed infection and antibody age-profiles in populations with urogenital schistosomiasis. PLoS Comput Biol 7:e1002237.
17. Guyatt HL, et al. (1994) Aggregation in schistosomiasis prevalence and intensity in different endemic areas. Parasitology 109:45-55. (Pubitemid 24231544)
18. Etard JF, Audibert M, Dabo A (1995) Age-acquired resistance and predisposition to reinfectionwith Schistosoma haematobium after treatment with praziquantel in Mali. Am J Trop Med Hyg 52:549-558.
19. Quinnell RJ, Grafen A, Woolhouse MEJ (1995) Changes in parasite aggregation with age: A discrete infection model. Parasitology 111:635-644. (Pubitemid 26027622)
20. Mutapi F, et al. (1998) Chemotherapy accelerates the development of acquired immune responses to Schistosoma haematobium infection. J Infect Dis 178:289-293. (Pubitemid 28328111)
21. Grogan JL, et al. (1996) Antischistosome IgG4 and IgE responses are affected differentially by chemotherapy in children versus adults. J Infect Dis 173:1242-1247. (Pubitemid 26251469)
22. Woolhouse MEJ, Etard JF, Dietz K, Ndhlovu PD, Chandiwana SK (1998) Heterogeneities in schistosome transmission dynamics and control. Parasitology 117:475-482. (Pubitemid 28505770)
23. Sabah AA, Fletcher C, Webbe G, Doenhoff M (1986) Schistosoma mansoni: Chemotherapy of infections of different ages. Exp Parasitol 61:294-303. (Pubitemid 16069841)
24. Gomes YM, et al. (2002) Antibody isotype responses to egg antigens in human chronic schistosomiasis mansoni before and after treatment. Mem Inst Oswaldo Cruz 97:111-112. (Pubitemid 41079978)
25. Agnew A, et al. (1996) Age-dependent reduction of schistosome fecundity in Schistosoma haematobium but not Schistosoma mansoni infections in humans. Am J Trop Med Hyg 55:338-343. (Pubitemid 26321843)
26. Agnew AM, et al. (1992) The susceptibility of adult schistosomes to immune attrition. Mem Inst Oswaldo Cruz 87:87-93.
27. Mutapi F, et al. (2005) Praziquantel treatment of individuals exposed to Schistosoma haematobium enhances serological recognition of defined parasite antigens. J Infect Dis 192:1108-1118. (Pubitemid 41266811)
28. Cao J, Liu S (1998) Immunization of mice with native tropomyosins from Schistosoma japonicum and Oncomelania hupensis. Chin J Parasitol Parasit Dis 16:401-405.
29. Zhang DM, et al. (2006) Investigation of recombinant Schistosoma japonicum paramyosin fragments for immunogenicity and vaccine efficacy in mice. Parasite Immunol 28:77-84.
30. Taylor MG, et al. (1998) Production and testing of Schistosoma japonicum candidate vaccine antigens in the natural ovine host. Vaccine 16:1290-1298. (Pubitemid 28308410)
31. Xu XD, et al. (2009) A Schistosoma japonicum chimeric protein with a novel adjuvant induced a polarized Th1 immune response and protection against liver egg burdens. BMC Infect Dis 9:54.
32. Miao Y-X, Liu S-X, McManus DP (1998) Isolation of native, biochemically purified triosephosphate isomerase from a Chinese strain of Schistosoma japonicum and its protective efficacy in mice. Parasitol Int 47:195-199. (Pubitemid 28530720)
33. Da'Dara AA, et al. (2008) DNA-based vaccines protect against zoonotic schistosomiasis in water buffalo. Vaccine 26:29-30.
34. Boulanger D, et al. (1999) Vaccine potential of a recombinant glutathione S-transferase cloned from Schistosoma haematobium in primates experimentally infected with an homologous challenge. Vaccine 17:319-326. (Pubitemid 28557178)
35. Riveau G, et al. (1998) Glutathione S-transferases of 28 kDa as major vaccine candidates against schistosomiasis. Mem Inst Oswaldo Cruz 93:87-94.
36. Ochsenbein AF, et al. (2000) Protective long-term antibody memory by antigen-driven and T help-dependent differentiation of long-lived memory B cells to short-lived plasma cells independent of secondary lymphoid organs. Proc Natl Acad Sci USA 97:13263-13268.
37. Radbruch A, et al. (2006) Competence and competition: The challenge of becoming a long-lived plasma cell. Nat Rev Immunol 6:741-750. (Pubitemid 44453460)
38. Mutapi F, et al. (2011) Differential recognition patterns of Schistosoma haematobium adult worm antigens by the human antibodies IgA, IgE, IgG1 and IgG4. Parasite Immunol 33:181-192.
39. de Vlas SJ (1996) Modelling humanSchistosoma mansoni infection: The art of counting eggs in faeces. PhD thesis (Erasmus, Rotterdam, The Netherlands).
40. Hairston NG (1965) On the mathematical analysis of schistosome populations. Bull World Health Organ 33:45-62.
41. Cheever AW, Kamel IA, Elwi AM, Mosimann JE, Danner R (1977) Schistosoma mansoni and S. haematobium infections in Egypt. II. Quantitative parasitological findings at necropsy. Am J Trop Med Hyg 26:702-716. (Pubitemid 8169291)
42. Woolhouse MEJ, Mutapi F, Ndhlovu PD, Chandiwana SK, Hagan P (2000) Exposure, infection and immune responses to Schistosoma haematobium in young children. Parasitology 120:37-44. (Pubitemid 30107721)
43. Chan MS, Mutapi F, Woolhouse MEJ, Isham VS (2000) Stochastic simulation and the detection of immunity to schistosome infections. Parasitology 120:161-169. (Pubitemid 30107740)
44. Mutapi F, et al. (2011) Schistosoma haematobium treatment in 1-5 year old children: Safety and efficacy of the antihelminthic drug praziquantel. PLoS Negl Trop Dis 5:e1143.
45. Mutapi F, et al. (2007) Cytokine responses to Schistosoma haematobium in a Zimbabwean population: Contrasting profiles for IFN-γ, IL-4, IL-5 and IL-10 with age. BMC Infect Dis 7:139.